| abstract |
Treatment methods and compositions for the treatment of fibrosis are provided. In some embodiments, these methods include augmentation of dendritic ceils for treatment of fibrosis. In some embodiments, fms-iike tyrosine kinase 3 ligartd (Flt3L) is used for the treatment of fibrosis and/or the augmentation of dendritic ceils, hi certain embodiments, the invention relates to methods for the treatment of fibrosis using Flt3L-expanded dendritic cells. In certain embodiments, the fibrosis is hepatic or pulmonary fibrosis. |